Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Almac Adds Mass Spec Lab | Contract Pharma

What are you searching for?

Sign in
Breaking News

Almac Adds Mass Spec Lab

Uses Agilent tech for new suite

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Almac has established a dedicated mass spectrometry laboratory in its European Headquarters at Craigavon, UK. The $1.5 million facility houses state-of-the-art mass spectrometers and “underlines Almac’s commitment to providing the best analytical facilities for its customers,” according to a company statement.

The investment of this laboratory and instruments substantially increases the company’s capabilities in solving complex analytical challenges. Instrumentation includes Quadrupole Time of Flight and Triple Quadrupole spectrometers for accurate mass and quantitation work. With this dedicated facility, Almac now offers an extended range of mass spectrometry services, including the quantitation of genotoxic impurities, bioanalysis, structure elucidation, isotopic purity determinations and high resolution mass spectrometry of both small and large molecules. Agilent Technologies was chosen as the preferred vendor to supply the suite of Mass Spectrometers to Almac.

Jon Cook, Almac’s head of Analytical Chemistry, commented, “This new mass spectrometry facility reinforces Almac’s vision of delivering the best for our customers and substantially enhances the level and depth of services we can provide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics